Skip to main content
Erschienen in: Pituitary 6/2015

01.12.2015

Impact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection

verfasst von: Garni Barkhoudarian, Aaron R. Cutler, Sam Yost, Bjorn Lobo, Amalia Eisenberg, Daniel F. Kelly

Erschienen in: Pituitary | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

With the resection of pituitary lesions, the anterior pituitary gland often obstructs transsphenoidal access to the lesion. In such cases, a gland incision and/or partial gland resection may be required to obtain adequate exposure. We investigate this technique and determine the associated risk of post-operative hypopituitarism.

Methods

All patients who underwent surgical resection of a pituitary adenoma or Rathke cleft cyst (RCC) between July 2007 and January 2013 were analyzed for pre- and post-operative hormone function. The cohort of patients with gland incision/resection were compared to a case-matched control cohort of pituitary surgery patients. Total hypophysectomy patients were excluded from outcome analysis.

Results

Of 372 operations over this period, an anterior pituitary gland incision or partial gland resection was performed in 79 cases (21.2 %). These include 53 gland incisions, 12 partial hemi-hypophysectomies and 14 resections of thinned/attenuated anterior gland. Diagnoses included 64 adenomas and 15 RCCs. New permanent hypopituitarism occurred in three patients (3.8 %), including permanent DI (3) and growth hormone deficiency (1). There was no significant difference in the rate of worsening gland dysfunction nor gain of function. Compared to a control cohort, there was a significantly lower incidence of transient DI (1.25 vs. 11.1 %, p = 0.009) but no significant difference in permanent DI (3.8 vs. 4.0 %) in the gland incision group.

Conclusion

Selective gland incisions and gland resections were performed in over 20 % of our cases. This technique appears to minimize traction on compressed normal pituitary gland during removal of large lesions and facilitates better visualization and removal of cysts, microadenomas and macroadenomas.
Literatur
1.
Zurück zum Zitat Chee GH, Mathias DB, James RA, Kendall-Taylor P (2001) Transsphenoidal pituitary surgery in Cushing’s disease: Can we predict outcome? Clin Endocrinol (Oxf) 54:617–626CrossRef Chee GH, Mathias DB, James RA, Kendall-Taylor P (2001) Transsphenoidal pituitary surgery in Cushing’s disease: Can we predict outcome? Clin Endocrinol (Oxf) 54:617–626CrossRef
3.
Zurück zum Zitat McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB (1993) Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol (Oxf) 38:79–86CrossRef McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB (1993) Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol (Oxf) 38:79–86CrossRef
4.
Zurück zum Zitat Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181–188CrossRef Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181–188CrossRef
5.
Zurück zum Zitat Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541–551CrossRef Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541–551CrossRef
6.
Zurück zum Zitat Semple PL, Webb MK, de Villiers JC, Laws ERJ (2005) Pituitary apoplexy. Neurosurgery 56:65–72PubMed Semple PL, Webb MK, de Villiers JC, Laws ERJ (2005) Pituitary apoplexy. Neurosurgery 56:65–72PubMed
9.
Zurück zum Zitat Arafah BUM (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas*. J Clin Endocrinol Metab 62(6):1173–1179CrossRefPubMed Arafah BUM (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas*. J Clin Endocrinol Metab 62(6):1173–1179CrossRefPubMed
10.
Zurück zum Zitat Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83(10):3411–3418CrossRefPubMed Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83(10):3411–3418CrossRefPubMed
11.
Zurück zum Zitat Cappabianca P, Cavallo LM, Colao A, de Divitiis E (2002) Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 97(2):293–298CrossRefPubMed Cappabianca P, Cavallo LM, Colao A, de Divitiis E (2002) Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 97(2):293–298CrossRefPubMed
12.
Zurück zum Zitat Nemergut EC, Zuo Z, Jane JA Jr, Laws ER Jr (2005) Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 103(3):448–454CrossRefPubMed Nemergut EC, Zuo Z, Jane JA Jr, Laws ER Jr (2005) Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 103(3):448–454CrossRefPubMed
13.
Zurück zum Zitat Gorczyca W, Hardy J (1987) Arterial supply of the human anterior pituitary gland. Neurosurgery 20(3):369–378CrossRefPubMed Gorczyca W, Hardy J (1987) Arterial supply of the human anterior pituitary gland. Neurosurgery 20(3):369–378CrossRefPubMed
14.
Zurück zum Zitat Dehdashti AR, Ganna A, Karabatsou K, Gentili F (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62(5):1006–1017CrossRefPubMed Dehdashti AR, Ganna A, Karabatsou K, Gentili F (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62(5):1006–1017CrossRefPubMed
15.
Zurück zum Zitat Gondim JA, Almeida JPC, Albuquerque LAF, Schops M, Gomes E, Ferraz T, Sobreira W, Kretzmann MT (2011) Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 14(2):174–183CrossRefPubMed Gondim JA, Almeida JPC, Albuquerque LAF, Schops M, Gomes E, Ferraz T, Sobreira W, Kretzmann MT (2011) Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 14(2):174–183CrossRefPubMed
16.
Zurück zum Zitat O’Malley BW Jr, Grady MS, Gabel BC, Cohen MA, Heuer GG, Pisapia J, Bohman L-E, Leibowitz JM (2008) Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. Neurosurg Focus 25(6):E10CrossRefPubMed O’Malley BW Jr, Grady MS, Gabel BC, Cohen MA, Heuer GG, Pisapia J, Bohman L-E, Leibowitz JM (2008) Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. Neurosurg Focus 25(6):E10CrossRefPubMed
17.
Zurück zum Zitat Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis: Clinical article. J Neurosurg 111(3):545–554CrossRefPubMed Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis: Clinical article. J Neurosurg 111(3):545–554CrossRefPubMed
18.
Zurück zum Zitat Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB Jr, Loriaux DL (1989) Repeat transsphenoidal surgery for Cushing’s disease. J Neurosurg 71(4):520–527CrossRefPubMed Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB Jr, Loriaux DL (1989) Repeat transsphenoidal surgery for Cushing’s disease. J Neurosurg 71(4):520–527CrossRefPubMed
19.
Zurück zum Zitat Biller B, Grossman AB, Stewart P, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus A, Hofland L (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454–2462PubMedCentralCrossRefPubMed Biller B, Grossman AB, Stewart P, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus A, Hofland L (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 93(7):2454–2462PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD (2005) Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 102(6):1004–1012CrossRefPubMed Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD (2005) Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 102(6):1004–1012CrossRefPubMed
21.
Zurück zum Zitat Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R (2003) Endonasal transsphenoidal approach to treat pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions of the surgery. J Neurosurg 98(2):350–358CrossRefPubMed Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R (2003) Endonasal transsphenoidal approach to treat pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions of the surgery. J Neurosurg 98(2):350–358CrossRefPubMed
22.
Zurück zum Zitat Cohan P, Foulad A, Esposito F, Martin N, Kelly D (2004) Symptomatic Rathke’s cleft cysts: a report of 24 cases. J Endocrinol Invest 27(10):943–948CrossRefPubMed Cohan P, Foulad A, Esposito F, Martin N, Kelly D (2004) Symptomatic Rathke’s cleft cysts: a report of 24 cases. J Endocrinol Invest 27(10):943–948CrossRefPubMed
23.
Zurück zum Zitat Barrow DL, Spector RH, Takei Y, Tindall GT (1985) Symptomatic Rathke’s cleft cysts located entirely in the suprasellar region: review of diagnosis, management, and pathogenesis. Neurosurgery 16(6):766–772CrossRefPubMed Barrow DL, Spector RH, Takei Y, Tindall GT (1985) Symptomatic Rathke’s cleft cysts located entirely in the suprasellar region: review of diagnosis, management, and pathogenesis. Neurosurgery 16(6):766–772CrossRefPubMed
24.
Zurück zum Zitat Kato T, Sawamura Y, Abe H, Nagashima M (1998) Transsphenoidal-transtuberculum sellae approach for supradiaphragmatic tumours: Technical note. Acta Neurochir (Wien) 140(7):715–719CrossRef Kato T, Sawamura Y, Abe H, Nagashima M (1998) Transsphenoidal-transtuberculum sellae approach for supradiaphragmatic tumours: Technical note. Acta Neurochir (Wien) 140(7):715–719CrossRef
25.
Zurück zum Zitat Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102(2):189–193CrossRefPubMed Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102(2):189–193CrossRefPubMed
26.
Zurück zum Zitat Ghirardello S, Hopper N, Albanese A, Maghnie M (2006) Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 19:413PubMed Ghirardello S, Hopper N, Albanese A, Maghnie M (2006) Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 19:413PubMed
Metadaten
Titel
Impact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection
verfasst von
Garni Barkhoudarian
Aaron R. Cutler
Sam Yost
Bjorn Lobo
Amalia Eisenberg
Daniel F. Kelly
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 6/2015
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-015-0664-3

Weitere Artikel der Ausgabe 6/2015

Pituitary 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.